Back
Fidelity Disruptive Medicine ETF Vs. Tema Obesity & Cardiometabolic ETF Industry Stock Comparison
Sell
43
FMED
Fidelity Disruptive Medicine ETF
Last Price:
26.20
Seasonality Move:
16.18%
Sell
11
HRTS
Tema Obesity & Cardiometabolic ETF
Last Price:
32.45
Seasonality Move:
--
Sell
43
Fidelity Disruptive Medicine ETF (FMED)
is a Sell
Is Fidelity Disruptive Medicine ETF a Buy, Sell or Hold?
- The current Fidelity Disruptive Medicine ETF [FMED] share price is $26.00. The Score for FMED is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- FMED is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
11
Tema Obesity & Cardiometabolic ETF (HRTS)
is a Sell
Is Tema Obesity & Cardiometabolic ETF a Buy, Sell or Hold?
- The current Tema Obesity & Cardiometabolic ETF [HRTS] share price is $32.87. The Score for HRTS is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- HRTS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
FMED Stock Price Chart
What is Fidelity Disruptive Medicine ETF's stock price today?
-
The Fidelity Disruptive Medicine ETF share price today is $26.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FMED is experiencing selling pressure, which indicates risk of future bearish movement.
HRTS Stock Price Chart
What is Tema Obesity & Cardiometabolic ETF's stock price today?
-
The Tema Obesity & Cardiometabolic ETF share price today is $32.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HRTS is experiencing selling pressure, which indicates risk of future bearish movement.
FMED Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 49.47 | Sell |
| Chaikin Money Flow: | -2690 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.79 - 26.27) | Sell |
| Bollinger Bands (100): | (24.67 - 26.21) | Buy |
HRTS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 41.63 | Sell |
| Chaikin Money Flow: | -13483 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.08 - 34.06) | Sell |
| Bollinger Bands (100): | (33.2 - 34.76) | Sell |
FMED Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.16 | Sell |
| 20-day SMA: | 26.02 | Sell |
| 50-day SMA: | 26.03 | Sell |
| 200-day SMA: | 24.97 | Buy |
| 8-day EMA: | 26.13 | Sell |
| 20-day EMA: | 26.05 | Sell |
| 50-day EMA: | 25.89 | Buy |
| 200-day EMA: | 24.95 | Buy |
HRTS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.48 | Sell |
| 20-day SMA: | 33.51 | Sell |
| 50-day SMA: | 33.78 | Sell |
| 200-day SMA: | 33.3 | Sell |
| 8-day EMA: | 33.41 | Sell |
| 20-day EMA: | 33.48 | Sell |
| 50-day EMA: | 33.67 | Sell |
| 200-day EMA: | 32.85 | Buy |
Fidelity Disruptive Medicine ETF Earnings Growth & FMED Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Tema Obesity & Cardiometabolic ETF Earnings Growth & HRTS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Fidelity Disruptive Medicine ETF Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Tema Obesity & Cardiometabolic ETF Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||